Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-90
SponsorKansas City Heart Rhythm Research Foundation

About this trial

This "How caffeine Induces Atrial Tachyarrhythmias" trial will be a multi-center, randomized, double-blinded trial of intravenous caffeine versus placebo among patients undergoing pulmonary vein isolation procedures for Atrial Fibrillation(AF).

Eligibility criteria

Qualifiers

None

Disqualifiers

History of substance abuse or alcoholism.

Left ventricular ejection fraction <50%.

Liver dysfunction.

Pregnancy.

Trial design

Treatments tested in this trial

  • Intravenous caffeine
  • Masked Placebo

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Kansas City Heart Rhythm Research Foundation

Lead sponsor

Kansas City Heart Rhythm Institute

Collaborator

Texas Cardiac Arrhythmia Institute, Austin, TX, USA

Collaborator

Loma Linda University, Loma Linda, California, USA

Collaborator